MIELOPTISIS Y CÁNCER GÁSTRICO. UNA ASOCIACIÓN INFRECUENTE.

Saved in:
Bibliographic Details
Title: MIELOPTISIS Y CÁNCER GÁSTRICO. UNA ASOCIACIÓN INFRECUENTE.
Alternate Title: Myelophthisis and gastric cancer. An unusual association.
Authors: ROMANO, JUAN PABLO1 juanpabloromano@hotmail.com, RODRIGUEZ, EDWIN1, LAMBERTO, FACUNDO N.1, PARRILLA, MARÍA MARTA2, BENITEZ, MARÍA PILAR3, AGUIAR, PABLO DÍAZ1
Source: Revista Medicina. Jul/Aug2019, Vol. 79 Issue 4, p295-298. 4p.
Abstract (English): The infiltration of the bone marrow y non-hematopoietic cells is called myelophthisis. In patients with gastric cancer, this invasion is extremely infrequent and the survival is usually less than three months. We present the case of a 35-year-old man with bone marrow involvement secondary to diffuse gastric carcinoma of signet ring cells. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Se denomina mieloptisis a la infiltración de la médula ósea por células no hematopoyéticas. En pacientes con cáncer gástrico esta invasión es extremadamente infrecuente y la supervivencia suele ser menor a tres meses. Presentamos el caso de un hombre de 35 años con compromiso de la médula ósea secundario a un carcinoma gástrico difuso de células en anillo de sello. [ABSTRACT FROM AUTHOR]
Copyright of Revista Medicina is the property of Revista Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:The infiltration of the bone marrow y non-hematopoietic cells is called myelophthisis. In patients with gastric cancer, this invasion is extremely infrequent and the survival is usually less than three months. We present the case of a 35-year-old man with bone marrow involvement secondary to diffuse gastric carcinoma of signet ring cells. [ABSTRACT FROM AUTHOR]
ISSN:13900218